Wearable Devices for Patient Monitoring in Long QT Syndrome
ConditionLong QT Syndrome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorQueen Mary University of London
About this trial
The main research question of this study is whether wearable devices have utility in monitoring patients with Long QT syndrome.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Clinical diagnosis of Long QT Syndrome
Aged 18 years or over
Phone with iOS version 15 or Android OS 9.0 or higher
Able and willing to provide informed consent
Disqualifiers
Unwilling or unable to give consent
Ventricular pacing at recruitment
Bundle branch block or pre-excitation at baseline
Trial population
Patients with a diagnosis of long QT syndrome
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Wearable device
DeviceThis is an observational study that does not impact routine clinical care for participants
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
1. Determine the accuracy of repeated QT interval measurements using Fitbit-derived ECGs in patients with Long QT syndrome compared with the current standard (12-lead ECG and ambulatory monitors)
Time frame
From enrollment to 3 months2
2. Establish intra-patient QT variability from weekly Fitbit-ECGs and frequency of measurements over 500ms.
Time frame
From enrollment to 3 monthsSecondary outcomes
1
1. Establish the utility of wearable devices for determining symptom aetiology in LQTS.
Time frame
From enrollment to 3 months2
2. Develop pipelines for the analysis of ECG data collected remotely including use of in-house QT automated algorithms for future machine learning applications.
Time frame
From enrollment to 3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov